中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2009年
45期
3193-3195
,共3页
徐迎胜%邓敏%张俊%郑菊阳%张朔%康德瑄%樊东升
徐迎勝%鄧敏%張俊%鄭菊暘%張朔%康德瑄%樊東升
서영성%산민%장준%정국양%장삭%강덕선%번동승
肌萎缩侧索硬化%运动单位数目估计%随访研究
肌萎縮側索硬化%運動單位數目估計%隨訪研究
기위축측색경화%운동단위수목고계%수방연구
Amyotrophic lateral sclerosis%Motor unit number estimation%Follow-up study
目的 探讨慢性运动轴索性神经病(CMAN)的特点及临床转归.方法 对16例临床和神经电生理确诊的慢性运动轴索性神经病患者进行随访研究,包括生存与否,用药情况,体征变化,运动单位数目估计.同时对60例肌萎缩侧索硬化(ALS)患者进行相关研究,比较两组病人的预后.结果 CMAN组经过丙种球蛋白治疗,随访18个月,6例进展为ALS,其余10例患者临床表现好转,MUNE值由68±17升为154±25,而ALS组肌无力、肌萎缩加重,MUNE值由64±6下降为55±9.结论 慢性运动轴索性神经病可能与免疫相关,预后良好,易与早期肌萎缩侧索硬化混淆.
目的 探討慢性運動軸索性神經病(CMAN)的特點及臨床轉歸.方法 對16例臨床和神經電生理確診的慢性運動軸索性神經病患者進行隨訪研究,包括生存與否,用藥情況,體徵變化,運動單位數目估計.同時對60例肌萎縮側索硬化(ALS)患者進行相關研究,比較兩組病人的預後.結果 CMAN組經過丙種毬蛋白治療,隨訪18箇月,6例進展為ALS,其餘10例患者臨床錶現好轉,MUNE值由68±17升為154±25,而ALS組肌無力、肌萎縮加重,MUNE值由64±6下降為55±9.結論 慢性運動軸索性神經病可能與免疫相關,預後良好,易與早期肌萎縮側索硬化混淆.
목적 탐토만성운동축색성신경병(CMAN)적특점급림상전귀.방법 대16례림상화신경전생리학진적만성운동축색성신경병환자진행수방연구,포괄생존여부,용약정황,체정변화,운동단위수목고계.동시대60례기위축측색경화(ALS)환자진행상관연구,비교량조병인적예후.결과 CMAN조경과병충구단백치료,수방18개월,6례진전위ALS,기여10례환자림상표현호전,MUNE치유68±17승위154±25,이ALS조기무력、기위축가중,MUNE치유64±6하강위55±9.결론 만성운동축색성신경병가능여면역상관,예후량호,역여조기기위축측색경화혼효.
Objective To study the characteristic of chronic motor axonal neuropathy and the prognosis of it.Methods 16 chronic motor axonal neuropathy (CMAN) patients were diagnosed by clinical manifestation and neurophysiologic manifestation.Follow-up study was clone including living state,medicine they taken,change of physical sign and motor unit number estimation.60 patients with amyotrophic lateral sclerosis were studies at the same time.The prognosis of these patients was compared.Results After being treated with intravenous immunoglobulin therapy,the patients with CMAN showed a good chnical recovery except 6 patients who had the characteristic of ALS in the 18 months follow-up study,and the MUNE changed from 68±17 to 154±25.On the contrary,the patients with ALS had worse clinical manifestation,and the MUNE changed from 64±6 to 55±9.Conclusions Immunological factor may be involved in the mechanism of chronic motor axonal neuropathy which has a better prognosis and is difficult to differentiate from amyotrophic lateral sclerosis in the earlier stage.